Signal Generation in the New Zealand Intensive Medicines Monitoring Programme: A Combined Clinical and Statistical Approach

Author： Coulter D.M.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.25, Iss.6, 2002-01, pp. : 433-439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence of Thrombotic Cardiovascular Events in Patients Taking Celecoxib Compared with Those Taking Rofecoxib: Interim Results from the New Zealand Intensive Medicines Monitoring Programme

By Harrison-Woolrych Mira  

Drug Safety, Vol. 28, Iss. 5, 2005-01 ,pp. : 435-442

Adis International

Access to resources Recommend Favorite

Activities to promote quality use of medicines in New Zealand

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 472, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

A Perspective on New Zealand's Medicines Regulatory Environment

By Richardson R.   Shaw I.   Nolan S.  

International Journal of Pharmaceutical Medicine, Vol. 17, Iss. 1, 2003-01 ,pp. : 17-22

Adis International

Access to resources Recommend Favorite

New Zealand Pharmacists and Pharmacist‐Only Medicines

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 4, 2004-12 ,pp. : 282-284

John Wiley & Sons Inc

Access to resources Recommend Favorite

Statistical Techniques for Signal Generation: The Australian Experience

By Purcell P.  

Drug Safety, Vol. 25, Iss. 6, 2002-01 ,pp. : 415-421

Adis International

Access to resources Recommend Favorite